Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Metabolism: Clinical and Experimental|June 11, 2016
Vagotomy and subsequent development of diabetes - A nested case-control studyJakob Starup-Linde, Michael Gejl, Per Borghammer, et al.Plos One|March 1, 2018
Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trialMads Svart, Lars C Gormsen, Jakob Hansen, et al.Frontiers in Pharmacology|December 6, 2016
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis RatsBrian DellaValle, Gitte S Brix, Birgitte Brock, et al.Diabetologia|August 2, 2019
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trialMalin Nilsson, Nicole Jensen, Michael Gejl, et al.Expert Opinion on Therapeutic Targets|July 14, 2011
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak, Lærke Egefjord, Michael Gejl, et al.The Journal of Clinical Endocrinology and Metabolism|August 26, 2024
Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysisNicole J Jensen, Ane J Porse, Helena Z Wodschow, et al.British Journal of Pharmacology|November 8, 2018
Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteriesMaj Bangshaab, Alejandro Gutierrez, Khiem Dinh Huynh, et al.Danish Medical Journal|November 20, 2012
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trialLærke Egefjord, Michael Gejl, Arne Møller, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 9, 2014
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patientsJohan Stender, Ron Kupers, Anders Rodell, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2012
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemiaMichael Gejl, Lærke Egefjord, Susanne Lerche, et al.Pageof 3